Tuberculosis contact investigation using interferon-gamma release assay with chest x-ray and computed tomography.

Between September 2009 and January 2010, 6 members of the Japanese Eastern Army, who had completed the same training program, were diagnosed with active tuberculosis (TB) on different occasions. The Ministry of Defense conducted a contact investigation of all members who had come into contact with the infected members. The purpose of this study was to verify the efficacy of the TB screening protocol used in this investigation. A total of 884 subjects underwent interferon-gamma release assay (IGRA) and chest X-ray. The 132 subjects who were IGRA positive or with X-ray findings suggestive of TB subsequently underwent chest computer tomography (CT). Chest CT was performed for 132 subjects. Based on CT findings, 24 (2.7%) subjects were classified into the active TB group, 107 (12.1%) into the latent tuberculosis infection (LTBI) group, and 753 (85.2%) into the non-TB group. The first 2 groups underwent anti-TB therapy, and all 3 groups were followed for 2 years after treatment. Although one subject in the active TB group experienced relapse during the follow-up period, no patient in the LTBI or non-TB groups developed TB. IGRA and chest X-ray, followed by chest CT for those IGRA positive or with suspicious X-ray findings, appears to be an effective means of TB contact screening and infection prevention.

Internal radiation exposure of Ground Self-Defense Force members involved in the management of the Fukushima Nuclear Power Plant disaster.

When the Great East Japan Earthquake occurred on March 11, 2011, the Ground Self-Defense Force (GSDF) was dispatched nationally to Northeast area in Japan. The highly trained GSDF members were simultaneously assigned to various missions for the Fukushima Nuclear Power Plants disaster. The missions of GSDF terminated on August 31, 2011. Special medical examinations were conducted for the members as they returned to each military unit. GSDF members who were assigned to the nuclear power plant were at risk of radiation exposure; therefore, pocket dosimeters were used to assess external radiation exposure. A few months after the mission was terminated, measurements of internal radiation exposure were performed. This is the first report of the internal exposure of GSDF members who worked in the restricted radiation contamination area. Here, we report the amounts of internal and external exposure of and the equipment used by the GSDF members.

Pseudomesotheliomatous lung cancer mimicking mesothelioma on ¹8F-FDG PET/CT images: report of 2 cases.

The authors report two cases of pseudomesotheliomatous lung cancer (PLC) detected by (18)F-FDG PET/CT scan. (18)F-FDG PET/CT clearly revealed the extent of the disease in both cases, a case of adenocarcinoma of the lung and a case of squamous cell carcinoma of the lung. Intense (18)F-FDG uptake by the diffusely thickened pleurae and primary lesion was observed in both cases, and increased (18)F-FDG uptake by a pelvic bone metastasis was observed in the case of squamous cell carcinoma. Although PLC is indistinguishable from malignant pleural mesothelioma on (18)F-FDG PET/CT scans, (18)F-FDG PET/CT was helpful in identifying the primary focus of the PLCs and in staging the disease. Diagnostic image interpreters should be familiar with the (18)F-FDG PET/CT findings in PLC.

Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.

OBJECTIVE: Elevated levels of serum carcinoembryonic antigen (CEA) in patients with colorectal cancer (CRC) during follow-up suggest recurrence, which can be visualized by (18)F-FDG PET/CT. Since the magnitude of CEA elevation reflects cancer volume, the ability of PET/CT to detect recurrence in patients with only mildly elevated CEA might be limited. However, the accuracy of PET/CT in detecting recurrence associated with elevated CEA has not been fully assessed. We retrospectively evaluated the diagnostic performance of (18)F-FDG PET/CT postoperatively relative to CEA levels among patients with CRC. METHODS: We visually assessed 75 PET/CT evaluations of 57 postoperative patients with CEA >5.0 ng/ml. Tumor volumes were also determined using image analysis software. The final diagnosis was confirmed based on histopathological findings, or at least on 6 months of clinical follow-up. RESULTS: Two lung cancers were excluded and we finally analyzed data from 73 of the 75 PET/CT evaluations. Recurrences were diagnosed in 54 (prevalence 74%). The sensitivity and specificity of PET/CT to detect recurrence was 50/54 (93%) and 14/19 (74%), respectively. The positive and negative predictive values were 91 and 78%, respectively, and the positive and negative likelihood ratios were 3.52 and 0.10, respectively. Values for the sensitivity of PET/CT were 88 and 95%, and those for specificity were 78 and 70%, at serum CEA concentrations of 5-10 and >10 ng/ml, respectively. Serum CEA (r = 0.500, p < 0.001) significantly correlated with cancer volumes. CONCLUSIONS: The present findings showed that (18)F-FDG PET/CT could accurately detect recurrent CRC irrespective of the elevated CEA concentration.

A case of incidentally detected IgG4-related sclerosing disease involving inflammatory abdominal aortic aneurysm and autoimmune pancreatitis.

A 59-year-old asymptomatic man was incidentally found to have a periaortic mass and an elevated serum amylase level during his medical check-up. Additional findings, such as infiltration of immunoglobulin G4 (IgG4)-producing plasma cells in the mass lesion, elevation of serum IgG4 (1000 mg/dl), and pancreatic duct narrowing as evidenced on a magnetic resonance cholangiopancreatography scan, confirmed the diagnosis as retroperitoneal fibrosis complicated with autoimmune pancreatitis. The patient responded favorably to steroid treatment before the appearance of symptoms.

Achilles tendon after percutaneous surgical repair: serial MRI observation of uncomplicated healing.

OBJECTIVE: The purpose of this study was to prospectively explore the MRI features of normal healing of the expected residual tendon gap in the Achilles tendon after percutaneous surgical repair. SUBJECTS AND METHODS: MR images of the Achilles tendon were obtained approximately 4, 8, and 12 weeks after surgery. Assessment of MR images was focused on the presence of residual tendon gap and gap length, Achilles tendon contour, and contrast enhancement in the ruptured area. Cases of open surgical repair were used for comparison. We attempted to statistically compare the timing of tendon gap disappearance within the percutaneous surgical repair group and between the percutaneous and open surgical repair groups. RESULTS: A total of 30 tendons repaired with percutaneous surgical technique and 10 repaired with open surgical technique were evaluated. At the first, second, and third MRI sessions of the percutaneous surgical repair group, a residual gap was found in 100%, 80%, and none of the tendons on T1-weighted images and in 87%, 63%, and none of the tendons on T2-weighted images. Achilles tendon contour was visualized in 30%, 90%, and 100% of the tendons on T1-weighted images and 90%, 100%, and 100% of the tendons on T2-weighted images. Intratendinous enhancement was present in 100%, 73%, and 7% of the tendons in the percutaneous surgical repair group. Ring-shaped peritendinous enhancement was recognized at the third session in all subjects. A significantly longer time was required for tendon gap disappearance after percutaneous than after open surgical repair. CONCLUSION: The time course of the MR findings in the ruptured Achilles tendon after percutaneous surgical repair appears to reflect regular healing.